Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Innospec (IOSP) Shares Outstanding (Diluted Average) (2017 - 2022)

Historic Shares Outstanding (Diluted Average) for Innospec (IOSP) over the last 12 years, with Q4 2022 value amounting to $25.0 million.

  • Innospec's Shares Outstanding (Diluted Average) rose 51.5% to $25.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was $25.0 million, marking a year-over-year increase of 51.5%. This contributed to the annual value of $25.0 million for FY2022, which is 51.5% up from last year.
  • Innospec's Shares Outstanding (Diluted Average) amounted to $25.0 million in Q4 2022, which was up 51.5% from $25.0 million recorded in Q3 2022.
  • Innospec's 5-year Shares Outstanding (Diluted Average) high stood at $25.0 million for Q4 2022, and its period low was $24.6 million during Q2 2020.
  • Over the past 5 years, Innospec's median Shares Outstanding (Diluted Average) value was $24.8 million (recorded in 2020), while the average stood at $24.8 million.
  • Per our database at Business Quant, Innospec's Shares Outstanding (Diluted Average) plummeted by 46.19% in 2020 and then surged by 124.17% in 2021.
  • Over the past 5 years, Innospec's Shares Outstanding (Diluted Average) (Quarter) stood at $24.6 million in 2018, then rose by 0.51% to $24.7 million in 2019, then rose by 0.21% to $24.8 million in 2020, then rose by 0.3% to $24.9 million in 2021, then increased by 0.52% to $25.0 million in 2022.
  • Its Shares Outstanding (Diluted Average) stands at $25.0 million for Q4 2022, versus $25.0 million for Q3 2022 and $25.0 million for Q2 2022.